Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Federal Trade Commission
Healthtrust
Fuji
Julphar
Express Scripts
Daiichi Sankyo
Chubb
Harvard Business School

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040889

« Back to Dashboard

NDA 040889 describes METHYLERGONOVINE MALEATE, which is a drug marketed by Breckenridge Pharm, Luitpold, Granules Pharms, and Novel Labs Inc, and is included in four NDAs. It is available from ten suppliers. Additional details are available on the METHYLERGONOVINE MALEATE profile page.

The generic ingredient in METHYLERGONOVINE MALEATE is methylergonovine maleate. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the methylergonovine maleate profile page.
Summary for 040889
Tradename:METHYLERGONOVINE MALEATE
Applicant:Breckenridge Pharm
Ingredient:methylergonovine maleate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 040889
Ingredient-typeErgolines
Medical Subject Heading (MeSH) Categories for 040889
Suppliers and Packaging for NDA: 040889
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHYLERGONOVINE MALEATE methylergonovine maleate INJECTABLE;INJECTION 040889 ANDA Akorn, Inc. 17478-501 E 17478-501-01
METHYLERGONOVINE MALEATE methylergonovine maleate INJECTABLE;INJECTION 040889 ANDA Breckenridge Pharmaceutical, Inc. 51991-144 N 51991-144-17

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.2MG/ML
Approval Date:Sep 13, 2010TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chubb
McKesson
Federal Trade Commission
Baxter
Cerilliant
Julphar
Healthtrust
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.